Tag

2025 Guidance

All articles tagged with #2025 guidance

business5 months ago

Eli Lilly Boosts 2025 Outlook Amid Strong Weight-Loss Drug Sales

Eli Lilly raised its 2025 sales and earnings guidance driven by strong demand for its weight loss and diabetes drugs Mounjaro and Zepbound, with second-quarter earnings surpassing estimates. The company also released trial data for its obesity pill, forglipron, which showed promising weight loss results but fell short of expectations, causing shares to drop. Despite robust revenue growth, Eli Lilly faces potential U.S. import tariffs and political pressure to lower drug prices.

business5 months ago

Tesla Faces Challenges Amidst Trade Uncertainties and Slowing EV Sales

Tesla has effectively given up on its previous forecast of returning to growth in electric vehicle deliveries in 2025, citing macroeconomic factors but largely reflecting a decline in demand possibly linked to brand issues caused by Elon Musk. The company reported a 13.5% drop in Q2 deliveries and has stopped providing specific future guidance, indicating a significant shift in its outlook.

business5 months ago

AT&T Q2 Earnings Surpass Estimates Despite Stock Decline

AT&T reported better-than-expected Q2 2025 earnings with adjusted EPS of 54 cents and revenue of $30.8 billion, driven by growth in 5G and fiber services. Despite beating estimates, its stock fell 3.39% in pre-market trading but remains up significantly year-to-date. The company provided a cautious outlook for 2025, with a potential EPS of $2.02, slightly below Wall Street estimates. Analysts maintain a strong buy rating with a 12% upside target, though stock performance may fluctuate as new analyst updates emerge.